Antibiotic prophylaxis for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) related complications in surgical patients

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 8, 2013, Pages

  Gurusamy, Kurinchi Selvan ^a   Koti, Rahul ^a   Wilson, Peter ^b   Davidson, Brian R ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFAMANDOLE; CEFAZOLIN; CEFMETAZOLE; CEFOTAXIME; CEFOTIAM; CEFUROXIME; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; LEVOFLOXACIN; OFLOXACIN; OXACILLIN; PEFLOXACIN; PENICILLIN DERIVATIVE; PIPERACILLIN; PLACEBO; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; BREAST SURGERY; CHEST INFECTION; COLORECTAL SURGERY; CORONARY ARTERY BYPASS GRAFT; ELECTIVE SURGERY; FRACTURE FIXATION; HEART SURGERY; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY RATE; NONHUMAN; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STERNOTOMY; SURGICAL INFECTION; SURGICAL PATIENT; SYSTEMATIC REVIEW; VASCULAR SURGERY; HETEROZYGOTE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; POSTOPERATIVE COMPLICATIONS; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION; STAPHYLOCOCCUS INFECTION;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CARRIER STATE; CEFOTAXIME; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION;

EID: 84893390369     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010268.pub2     Document Type: Review

References (100)

1. Carsenti-Etesse H, Doyon F, Desplaces N, Gagey O, Tancrède C, Pradier C, et al. Epidemiology of bacterial infection during management of open leg fractures. European Journal of Clinical Microbiology & Infectious Diseases 1999;18(5):315-23.
2. Goldstein EJ, Citron DM, Merriam CV, Abramson MA. Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis. Surgical Infections 2009;10(2):111-8.
3. Hashizume T, Nishizawa R, Aizawa S, Yamaya M, Kobori H, Asakura Y, et al. Clinical study of using prophylactic antibiotics and chemical preparation for elective operation of colorectal cancer. Japanese Journal of Gastroenterological Surgery 2004;37(4):375-83.
4. Ishibashi K, Kuwabara K, Ishiguro T, Ohsawa T, Okada N, Miyazaki T, et al. Short-term intravenous antimicrobial prophylaxis in combination with preoperative oral antibiotics on surgical site infection and methicillin-resistant Staphylococcus aureus infection in elective colon cancer surgery: results of a prospective randomized trial. Surgery Today 2009;39(12):1032-9.
5. Ishida H, Yokoyama M, Nakada H, Inokuma S, Hashimoto D. Impact of oral antimicrobial prophylaxis on surgical site infection and methicillin-resistant Staphylococcus aureus infection after elective colorectal surgery. Results of a prospective randomized trial. Surgery Today 2001;31(11):979-83.
6. Kaiser AB, Petracek MR, Lea JW, Kernodle DS, Roach AC, Alford WC, et al. Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1030 patients. Annals of Surgery 1987;206(6):791-7.
7. Morimoto K, Koh M, Kinoshita H. Levofloxacin for prophylaxis in breast cancer surgery compared with ofloxacin. Japanese Journal of Antibiotics 2002;55(6):866-74.
8. Saadeddin A, Freshwater DA, Fisher NC, Jones BJM. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy for non-malignant conditions: A double-blind prospective randomized controlled trial. Alimentary Pharmacology and Therapeutics 2005;22(6):565-70.
9. Saveli CC, Morgan SJ, Belknap RW, Ross E, Stahel PF, Chaus GW, et al. The role of antibiotics in open fractures revisited: Characteristics of Staphylococcus aureus (SA) and susceptibility profile. Surgical infections 2011;12(S1):S38-9.
10. Shime N, Kato Y, Kosaka T, Kokufu T, Yamagishi M, Fujita N. Glycopeptide pharmacokinetics in current paediatric cardiac surgery practice. European Journal of Cardio-Thoracic Surgery 2007;32(4):577-81.
11. Stone P, Campbell J, AbuRahma A, Safley L, Emmett M, Asmita M. Vascular surgical antibiotic prophylaxis study (VSAPS). Vascular and Endovascular Surgery 2010;44(7):521-8.
12. Stone PA, AbuRahma AF. Vascular surgical antibiotic prophylactic study (VSAPS). Journal of Vascular Surgery 2009;50(6):1533.
13. Vuorisalo S, Pokela R, Syrjala H. Comparison of vancomycin and cefuroxime for infection prophylaxis in coronary artery bypass surgery. Infection Control and Hospital Epidemiology 1998;19(4):234-9.
14. Al-Mukhtar A, Wong VK, Malik HZ, Abu-Hilal M, Denton M, Wilcox M, et al. A simple prophylaxis regimen for MRSA: its impact on the incidence of infection in patients undergoing liver resection. Annals of the Royal College of Surgeons of England 2009;91(1):35-8.
15. Bluhm G, Jacobson B, Julander I, Levander-Lindgren M, Olin C. Antibiotic prophylaxis in pacemaker surgery--a prospective study. Scandinavian Journal of Thoracic and Cardiovascular Surgery 1984;18(3):227-34.
16. Cann KJ, Watkins RM, George C, Payne-James J, Crawfurd E, Rogers TR. A trial of mezlocillin versus cefuroxime with or without metronidazole for the prevention of wound sepsis after biliary and gastrointestinal surgery. Journal of Hospital Infection 1988;12(3):207-14.
17. Dhadwal K, Al-Ruzzeh S, Athanasiou T, Choudhury M, Tekkis P, Vuddamalay P, et al. Comparison of clinical and economic outcomes of two antibiotic prophylaxis regimens for sternal wound infection in high-risk patients following coronary artery bypass grafting surgery: a prospective randomised double-blind controlled trial. Heart 2007;93(9):1126-33.
18. Diehr S, Hamp A, Jamieson B. Do topical antibiotics improve wound healing?. Journal of Family Practice 2007;56(2):140-4.
19. Finkelstein R, Rabino G, Mashiah T, Bar-El Y, Adler Z, Kertzman V, et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. Journal of Thoracic and Cardiovascular Surgery 2002;123(2):326-32.
20. Frimodt-Moller N, Ostri P, Pedersen IK, Poulsen SR. Antibiotic prophylaxis in pulmonary surgery: a double-blind study of penicillin versus placebo. Annals of Surgery 1982;195(4):444-50.
21. Kanellakopoulou K, Papadopoulos A, Varvaroussis D, Varvaroussis A, Giamarellos-Bourboulis EJ, Pagonas A, et al. Efficacy of teicoplanin for the prevention of surgical site infections after total hip or knee arthroplasty: a prospective, open-label study. International Journal of Antimicrobial Agents 2009;33(5):437-40.
22. Kato D, Maezawa K, Yonezawa I, Iwase Y, Ikeda H, Nozawa M, et al. Randomized prospective study on prophylactic antibiotics in clean orthopedic surgery in one ward for 1 year. Journal of Orthopaedic Science 2006;11(1):20-7.
23. Keighley MR, Arabi Y, Alexander-Williams J, Youngs D, Burdon DW. Comparison between systemic and oral antimicrobial prophylaxis in colorectal surgery. Lancet 1979;313(8122):894-7.
24. Maki DG, Bohn MJ, Stolz SM, Kroncke GM, Acher CW, Myerowitz PD. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial. Journal of Thoracic and Cardiovascular Surgery 1992;104(5):1423-34.
25. Marroni M, Cao P, Fiorio M, Maghini M, Lenti M, Repetto A, et al. Prospective, randomized, double-blind trial comparing teicoplanin and cefazolin as antibiotic prophylaxis in prosthetic vascular surgery. European Journal of Clinical Microbiology and Infectious Diseases 1999;18(3):175-8.
26. Mindermann T, Zimmerli W, Gratzl O. Randomized placebo-controlled trial of single-dose antibiotic prophylaxis with fusidic acid in neurosurgery. Acta Neurochirurgica 1993;121(1-2):9-11.
27. Palmer DL, Pett SB, Akl BF. Bacterial wound colonization after broad-spectrum versus narrow-spectrum antibiotics. Annals of Thoracic Surgery 1995;59(3):626-31.
28. Poon WS, Ng S, Wai S. CSF antibiotic prophylaxis for neurosurgical patients with ventriculostomy: a randomised study. Acta Neurochirurgica. Supplement 1998;71:146-8.
29. Ramos G, Resta M, Delgado EM, Durlach R, Canigia LF, Benaim F. Systemic perioperative antibiotic prophylaxis may improve skin autograft survival in patients with acute burns. Journal of Burn Care and Research 2008;29(6):917-23.
30. Saginur R, Croteau D, Bergeron MG. Comparative efficacy of teicoplanin and cefazolin for cardiac operation prophylaxis in 3027 patients The ESPRIT Group. Journal of Thoracic and Cardiovascular Surgery 2000;120(6):1120-30.
31. Salminen US, Viljanen TU, Valtonen VV, Ikonen TE, Sahlman AE, Harjula AL. Ceftriaxone versus vancomycin prophylaxis in cardiovascular surgery. Journal of Antimicrobial Chemotherapy 1999;44(2):287-90.
32. Tacconelli E, Cataldo MA, Albanese A, Tumbarello M, Arduini E, Spanu T, et al. Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus. Journal of Hospital Infection 2008;69(4):337-44.
33. Tyllianakis ME, Karageorgos A, Marangos MN, Saridis AG, Lambiris EE. Antibiotic prophylaxis in primary hip and knee arthroplasty: comparison between cefuroxime and two specific antistaphylococcal agents. Journal of Arthroplasty 2010;25(7):1078-82.
34. Weaver M, Burdon DW, Youngs DJ, Keighley MR. Oral neomycin and erythromycin compared with single-dose systemic metronidazole and ceftriaxone prophylaxis in elective colorectal surgery. American Journal of Surgery 1986;151(4):437-42.
35. Wilson AP, Treasure T, Gruneberg RN, Sturridge MF, Ross DN. Antibiotic prophylaxis in cardiac surgery: a prospective comparison of two dosage regimens of teicoplanin with a combination of flucloxacillin and tobramycin. Journal of Antimicrobial Chemotherapy 1988;21(2):213-23.
36. Alou L, Cafini F, Sevillano D, Unzueta I, Prieto J. In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin. International Journal of Antimicrobial Agents 2004;23(5):513-6.
37. Barber M. Methicillin-resistant staphylococci. Journal of Clinical Pathology 1961;14:385-93.
38. Boyce JM, Jackson MM, Pugliese G, Batt MD, Fleming D, Garner JS, et al. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. Infection Control and Hospital Epidemiology 1994;15(2):105-15.
39. Cantoni L, Wenger A, Glauser MP, Bille J. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats. The Journal of Infectious Diseases 1989;159(5):989-93.
40. Chambers D, Worthy G, Myers L, Weatherly H, Elliott R, Hawkins N, et al. Glycopeptide vs. non-glycopeptide antibiotics for prophylaxis of surgical site infections: a systematic review. Surgical Infections 2010;11(5):455-62.
41. Chemaly RF, Hachem RY, Husni RN, Bahna B, Rjaili GA, Waked A, et al. Characteristics and outcomes of methicillin-resistant Staphylococcus aureus surgical-site infections in patients with cancer: a case-control study. Annals of Surgical Oncology 2010;17(6):1499-506.
42. Chua T, Moore CL, Perri MB, Donabedian SM, Masch W, Vager D, et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit. Journal of Clinical Microbiology 2008;46(7):2345-52.
43. Cowie SE, Ma I, Lee SK, Smith RM, Hsiang YN. Nosocomial MRSA infection in vascular surgery patients: impact on patient outcome. Vascular and Endovascular Surgery 2005;39(4):327-34.
44. Creamer E, Galvin S, Dolan A, Sherlock O, Dimitrov BD, Fitzgerald-Hughes D, et al. Evaluation of screening risk and non risk patients for methicillin-resistant Staphylococcus aureus on admission in an acute care hospital. American Journal of Infection Control 2012;40(5):411-5.
45. DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341-50.
46. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
47. ECDC. European Centre for Disease Prevention and Control. Annual epidemiological report on communicable diseases in Europe. http://www.ecdc.europa.eu/en/publications/Publications/0910_SUR_Annual_Epidemiological_Report_on_Communicable_Diseases_in_Europe.pdf 2009 (accessed on 17 July 2011).
48. ECDC. European Centre for Disease Prevention and Control. The bacterial challenge: time to react. A call to narrow the gap between multi-drug resistant bacteria in the EU and the development of new anti-bacterial agents. http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf 2009 (accessed on 17 July 2011).
49. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
50. Fraser S, Brady R, Graham C, Paterson-Brown S, Gibb A. Methicillin-resistant staphylococcus aureus in surgical patients: Identification of high-risk populations for the development of targeted screening programmes. Annals of the Royal College of Surgeons of England 2010;92(4):311-5.
51. Garner JS. CDC guideline for prevention of surgical wound infections, 1985. Infection Control 1986;7(3):193-200.
52. Gurusamy K, Koti R, Toon C, Wilson P, Davidson BR. Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in surgical wounds. Cochrane Database of Systematic Reviews In Press.
53. Gurusamy KS, Gluud C, Nikolova D, Davidson BR. Assessment of risk of bias in randomized clinical trials in surgery. British Journal of Surgery 2009;96(4):342-9.
54. Harbarth S, Huttner B, Gervaz P, Fankhauser C, Chraiti MN, Schrenzel J, et al. Risk factors for methicillin-resistant Staphylococcus aureus surgical site infection. Infection Control and Hospital Epidemiology 2008;29(9):890-3.
55. Harbarth S, Fankhauser C, Schrenzel J, Christenson J, Gervaz P, Bandiera-Clerc C, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008;299(10):1149-57.
56. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58.
57. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Colloboration, 2011. Available from www.cochrane-handbook.org.
58. Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
59. Higgins JPT, Deeks JJ and Altman DG on behalf of the Cochrane Statistical Methods Group (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
60. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infection Control and Hospital Epidemiology 1992;13(10):606-8.
61. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Code of Federal Regulation & ICH Guidelines. Media: Parexel Barnett, 1996.
62. Jevons PM. "Celbenin" - resistant Staphylococci. British Medical Journal 1961;1(5219):124-5.
63. Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010;304(6):641-8.
64. Kang J, Mandsager P, Biddle AK, Weber DJ. Cost-effectiveness analysis of active surveillance screening for methicillin-resistant Staphylococcus aureus in an academic hospital setting. Infection Control and Hospital Epidemiology 2012;33(5):477-86.
65. Kaye KS, Anderson DJ, Choi Y, Link K, Thacker P, Sexton DJ. The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals. Clinical Infectious Diseases 2008;46(10):1568-77.
66. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
67. Klimek JJ, Marsik FJ, Bartlett RC, Weir B, Shea P, Quintiliani R. Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital. American Journal of Medicine 1976;61(3):340-5.
68. Knox R, Smith JT. The nature of penicillin resistance in staphylococci. Lancet 1961;2(7201):520-2.
69. Kuehnert MJ, Hill HA, Kupronis BA, Tokars JI, Solomon SL, Jernigan DB. Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerging Infectious Diseases 2005;11(6):868-72.
70. Lamagni TL, Potz N, Powell D, Pebody R, Wilson J, Duckworth G. Mortality in patients with meticillin-resistant Staphylococcus aureus bacteraemia, England 2004-2005. Journal of Hospital Infection 2011;77(1):16-20.
71. Lefebvre C, Manheimer E, Glanville J on behalf of the Cochrane Information Retrieval Methods Group. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
72. Lewis T, Chaudhry R, Nightingale P, Lambert P, Das I. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK. International Journal of Infectious Diseases 2011;15(2):e131-5.
73. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clinical Infectious Diseases 2011;52(3):285-92.
74. Loeb MB, Main C, Eady A, Walkers-Dilks C. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD003340]
75. Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Statistics in Medicine 2001;20(4):641-54.
76. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13.
77. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infection Control and Hospital Epidemiology 2003;24(5):362-86.
78. Newell DJ. Intention-to-treat analysis: implications for quantitative and qualitative research. International Journal of Epidemiology 1992;21(5):837-41.
79. O'Toole RD, Drew WL, Dahlgren BJ, Beaty HN. An outbreak of methicillin-resistant Staphylococcus aureus infection. Observations in hospital and nursing home. JAMA 1970;213(2):257-63.
80. OED. Oxford English dictionary. The definitive record of the English language. http://www.oed.com/2011 (accessed on 7 April, 2011).
81. Otter JA, French GL. Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. Journal of Hospital Infection 2011;79(3):189-93.
82. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
83. Prieto J, Aguilar L, Gimenez MJ, Toro D, Gomez-Lus ML, Dal-Re R, et al. In vitro activities of co-amoxiclav at concentrations achieved in human serum against the resistant subpopulation of heteroresistant Staphylococcus aureus: a controlled study with vancomycin. Antimicrobial Agents and Chemotherapy 1998;42(7):1574-7.
84. Reddy SL, Grayson AD, Smith G, Warwick R, Chalmers JA. Methicillin resistant Staphylococcus aureus infections following cardiac surgery: incidence, impact and identifying adverse outcome traits. European Journal of Cardio-Thoracic Surgery 2007;32(1):113-7.
85. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
86. Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. Journal of Bone and Joint Surgery. British Volume 2005;87(6):844-50.
87. Sanjay P, Fawzi A, Kulli C, Polignano FM, Tait IS. Impact of methicillin-resistant Staphylococcus aureus (MRSA) infection on patient outcome after pancreatoduodenectomy (PD)--a cause for concern?. Pancreas 2010;39(8):1211-4.
88. Schroeder MS. Clostridium difficile--associated diarrhea. American Family Physician 2005;71(5):921-8.
89. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
90. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and Summary of findings' tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
91. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, Guyatt GH. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
92. Shukla S, Nixon M, Acharya M, Korim MT, Pandey R. Incidence of MRSA surgical-site infection in MRSA carriers in an orthopaedic trauma unit. Journal of Bone and Joint Surgery. British Volume 2009;91(2):225-8.
93. Sieradzki K, Roberts RB, Haber SW, Tomasz A. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. New England Journal of Medicine 1999;340(7):517-23.
94. Scottish Intercollegiate Guidelines Network (SIGN). Antibiotic prophylaxis in surgery. A national clinical guideline. http://www.sign.ac.uk/pdf/sign104.pdf 2008 (accessed 14 February 2013); Vol. 104.
95. Scottish Intercollegiate Guidelines Network (SIGN). Search filters. http://www.sign.ac.uk/methodology/filters.html#random (Accessed May 23 2013).
96. Skov R, SSAC MRSA Working Party. MRSA infections increasing in the Nordic countries. Euro Surveillance 2005;10(31):E050804.2.
97. Spence MR, Dammel T, Courser S. Contact precautions for methicillin-resistant Staphylococcus aureus colonization: costly and unnecessary?. American Journal of Infection Control 2012;40(6):535-8.
98. Wang JT, Wang JL, Fang CT, Chie WC, Lai MS, Lauderdale TL, et al. Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: with investigation of the potential role of community-associated MRSA strains. Journal of Infection 2010;61(6):449-57.
99. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336(7544):601-5.
100. Wulf M, Voss A. MRSA in livestock animals-an epidemic waiting to happen?. Clinical Microbiology and Infection 2008;14(6):519-21.